Delivery of SAR 1118 to the Retina via Ophthalmic Drops and its Effectiveness in a Rat Streptozotocin (STZ) Model of Diabetic Retinopathy (DR)
Investigative Ophthalmology & Visual Science2010Vol. 51(10), pp. 5198–5198
Citations Over TimeTop 10% of 2010 papers
Vidhya R. Rao, Elizabeth Prescott, Namdev B. Shelke, Ruchit Trivedi, Peter Thomas, Craig B Struble, Tom Gadek, Charles O’Neill, Uday B. Kompella
Abstract
SAR 1118 ophthalmic drops administered thrice daily deliver therapeutic levels of SAR 1118 in the retina and can alleviate the retinal complications associated with diabetes.
Related Papers
- → Spatial distribution of early red lesions is a risk factor for development of vision-threatening diabetic retinopathy(2017)17 cited
- Prevalence of diabetic retinopathy at Parirenyatwa hospital(2016)
- [The changes of histology and biochemical parameters in retina of the patient with diabetic retinopathy].(2004)
- Expression and Significance of Macrophage Migration Inhibitory Factor in the Retina of Diabetic Rats(2009)
- → The relationship of serum 8-hydroxydeoxyguanosin to diabetic retinopathy(2014)